# The Gut Immune System During Immune Checkpoint Inhibitor Therapy

> **NCT04600180** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 38 (estimated)

## Conditions studied

- Cancer

## Interventions

- **PROCEDURE:** sigmoidoscopies and and venous blood sampling

## Key facts

- **NCT ID:** NCT04600180
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-10-30
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04600180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04600180, "The Gut Immune System During Immune Checkpoint Inhibitor Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04600180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*